StockGlow

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People's Republic of China, the United States, and internationally.

50.15+0.04%Healthcare
Compare 2315.HK with
StockGlow Score
82
Bullish
BearishBullish
1 year ago+97.1%

The outlook

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. currently reads as bullish based on above its 50- & 200-day averages, 60% of the way from its 52-week low to high, avg target +24% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range60% of the way from its 52-week low to high
Price targetAvg target +24% vs current price
Market cap
$22.24B
52-wk high
70.15
52-wk low
20.30
50-day avg
46.99
200-day avg
44.18
Trailing P/E
100.3

Similar stocks

2251.HKBeijing Airdoc Technology Co., Ltd.$9.78-3.17%2256.HKAbbisko Cayman Limited$10.09+4.56%2325.HKYunkang Group Limited$0.59-7.81%2291.HKLEPU ScienTech Medical Technology (Shanghai) Co., Ltd.$11.92+1.79%2392.HKXuan Wu Cloud Technology Holdings Limited$1.06+0.95%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy